SCHEMBL2805165

SCHEMBL2805165

CNc1ncc2c(n1)-c1ccccc1C1(CCN(C(=O)NCc3ccccc3)CC1)C2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.46
HDAC1 Q13547 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP46A1 Q9Y6A2 1/20 0.41
GRIN2B Q13224 1/20 0.41
NAMPT P43490 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CCNA2 P20248 2/20 0.39
CDK2 P24941 2/20 0.39
CCNA1 P78396 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SMO Q99835 1/20 0.39
USP19 O94966 1/20 0.38
AURKA O14965 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
NPY5R Q15761 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2805167 1.00 MAPK1 (0.46) MAPK1HDAC1HDAC8HDAC6KDM4E
SCHEMBL2806557 0.88 HDAC3 (0.42) HDAC1HDAC6KDM4EALDH1A1CCNA2
SCHEMBL2806554 0.88 HDAC3 (0.42) HDAC1HDAC6KDM4EALDH1A1CCNA2
SCHEMBL2805032 0.87 MEN1 (0.41) HDAC1HDAC8HDAC6KDM4ENAMPT
SCHEMBL2802647 0.86 NPY5R (0.43) HDAC1HDAC6KDM4EALDH1A1NPY5R
SCHEMBL2802649 0.86 NPY5R (0.43) HDAC1HDAC6KDM4EALDH1A1NPY5R
SCHEMBL2805142 0.85 HDAC1 (0.40) HDAC1HDAC6KDM4EALDH1A1CCNA2
SCHEMBL2802255 0.84 CYP1A2 (0.43) MAPK1ALDH1A1CCNA2CDK2CCNA1
SCHEMBL2808109 0.82 SIGMAR1 (0.51)
SCHEMBL2802712 0.82 HDAC3 (0.47) HDAC1HDAC6KDM4ENAMPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 MAPK1 2878/4885HDAC1 1006/4885HDAC8 1570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.